Location: Cambridge Breadth of research use rights now expanded to include multiple new species Grant of rights to have products made and sold by partners Grant of sub-licensed rights to one spin-out company Cambridge, UK, and Dublin, Ireland: Horizon Discovery Group plc (LSE: HZD) (“Horizon” or “the Group”), a global leader in gene editing and […]

SAN DIEGO, CA and CAMBRIDGE, MA — Edico Genome and Seven Bridges today announced the availability of Edico Genome’s DRAGENTM pipelines within Seven Bridges’ cloud-based data ecosystem. Edico Genome’s DRAGEN Germline V2, DRAGEN Somatic V2 and DRAGEN RNA Gene Fusion Detection Pipelines are now live on the Seven Bridges platform, enabling customers to leverage DRAGEN’s ultra rapid speeds and accuracy. Seven Bridges […]

Shimadzu Corporation, Fujitsu Limited, and Fujitsu Laboratories Ltd. are undertaking collaborative research*1to develop technology that utilizes AI (artificial intelligence) to process the vast amounts of data used in analyzing the measurement results, which are essential to analytical processes, acquired from Shimadzu mass spectrometers. Fujitsu, an information and communication technology company, has been exploring the creation […]

This year’s Simcyp Simulator enhancements include new oncology and preterm-birth populations, enhanced skin and gut transporter models, and additional regulatory qualification summaries PRINCETON, NJ – Certara®, the global leader in model-informed drug development and regulatory science, today announced that it has launched version 17 of its Simcyp® Population-based Simulator. “We are proud to introduce several significant advances […]

Across many scientific disciplines, but in particular in the field of genomics, major breakthroughs have often resulted from new technologies. From Sanger sequencing, which made it possible to sequence the human genome, to the microarray technologies that enabled the first large-scale genome-wide experiments, new instruments and tools have allowed us to look ever more deeply into the genome […]

LAS VEGAS — Today at AWS re:Invent, Edico Genome revealed its DRAGEN Complete Suite (DRAGEN CS) on AWS Marketplace, a comprehensive package of pipelines that enables AWS users to access all of DRAGEN’s applications for next-generation sequencing (NGS) data analysis in one click. Pieter van Rooyen, Ph.D., president and CEO at Edico Genome, and Rami Mehio, vice president of […]

RowAnalytics has combined artificial intelligence, semantics and science in an unprecedented manner to truly enable precision medicine. Their technology is the first with the capability of analyzing all forms of biological, genomic and clinical data (including scans and images) together at the same time. Moreover, they are the first with the capability of analyzing all […]

Tailored Workflows and Curated Analytics Provide Visibility Across Relevant Data Domains for Medical Monitors   WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of PerkinElmer Signals™ Medical Review.  This new cloud-based analytics and visualization solution provides medical monitors in clinical development with smarter insights to quickly detect safety signals […]

Tel Aviv Sourasky Medical Center and NRGene research exploring protection again neurodegenerative disease Tel Aviv & Ness Ziona, Israel – NRGene, the worldwide leader in genomic assembly and analysis, has partnered with the Genetic Institute of Tel Aviv Sourasky Medical Center (TASMC) to perform genomic analysis of Parkinson’s disease (PD). “Our collaboration with NRGene and […]

Paris, France, and London, UK: Today, Biomillenia, the developer of Smart Microbes™, announced its collaboration with QIAGEN N.V. (NASDAQ: QGEN, Frankfurt Stock Exchange: QIA) for use of QIAGEN’Ss Microbial Genomics Pro Suite to generate next-generation sequence data on microbes identified using Biomillenia’s proprietary microbe-on-a-chip technology. Biomillenia’s approach can identify strains of microbes previously deemed unculturable, and do so […]